The Limited Times

Now you can see non-English news...

Covid: Argentina, 1% 'adverse events' with Sputnik V vaccine

2021-01-03T11:28:35.825Z


The Argentine Minister of Health Ginés González García announced that compared to the top 32. (ANSA) (ANSA) - BUENOS AIRES, JAN 3 - The Argentine Health Minister Ginés González García has announced that in the face of the first 32,013 vaccinations of health personnel throughout the country carried out with the Russian Sputnik V vaccine, there have been 317 "adverse events", of which "99.3% classified as mild or moderate".     Speaking in the controversy raised in Argentina on the safety of the v


(ANSA) - BUENOS AIRES, JAN 3 - The Argentine Health Minister Ginés González García has announced that in the face of the first 32,013 vaccinations of health personnel throughout the country carried out with the Russian Sputnik V vaccine, there have been 317 "adverse events", of which "99.3% classified as mild or moderate".


    Speaking in the controversy raised in Argentina on the safety of the vaccine produced by the Russian laboratory Gamaleya, García underlined via Twitter that "it is a 1%" and that "the presence of fever, headache or muscle pain, as unique or associated symptoms, concerned the 80% of the events recorded ".


    The minister then recalled that "in the case of the manifestation of these symptoms, they appear within six hours of administering the vaccine and disappear within 24-48 hours".


    For his part, the Deputy Minister of Health of the government of the city of Buenos Aires, Nicolás Kreplak, commented that "the reactions recorded with Sputnik V are similar to those observed in the administration of other vaccines".


    In recent days, the data on infections have worsened in Argentina: the Ministry of Health reported that from December 31 to January 2 the infections were 20,906, for a total of 1,634,834 from March.

The dead were 212, with a total budget of 43,375. (ANSA).


Source: ansa

All life articles on 2021-01-03

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.